HalioDx masters assay development on various technologies: immunohistochemistry, digital pathology, high throughput Next Generation Sequencing, quantitative PCR and nCounter® technology (Nanostring).
Depending on your project, our team can help you defining the adequate assay to support your research and scientific questions you might have.
HalioDx already developed several IHC on-demand tests that are now available in the portfolio like:
- NKp46*,
- Granzyme B,
- CD68,
- IDO,
- Ki67,
- MHC Class I,
- MHC Class II,
- CD25/FoxP3,
- etc…
* HalioDx proprietary assay
- Pharma Services
- Immunogram
- Our offer within the TME
- Immunoscore® CR
- Brightplex®
- Immunosign®
- IO Sequencing
- Biostats
- On demand Assays
- The Cancer Immune Atlas
